Skip to Content
PR Newswire

Break Free from Marijuana Addiction with New 30-Day Online Program

Break Free from Marijuana Addiction with New 30-Day Online Program

Break Free from Marijuana Addiction with New 30-Day Online Program

Dr. Tony DeRamus, D.C offers an easier path to recovery!

PR Newswire

MAGNOLIA, Texas, July 26, 2021

MAGNOLIA, Texas, July 26, 2021 /PRNewswire/ -- Dr. Tony DeRamus, D.C has just launched the new CAARE Program. An innovative way to overcome marijuana addiction in the comfort of a customer's own home. The CAARE Program is a 30-day step-by-step program that has the tools needed to overcome marijuana addiction. The course is designed to help people take actionable steps every day to overcome their addiction.

The CAARE Program is divided into three sections. In the first section, users complete questionnaires and activities to dive deep into the psychology of why people are addicted. Next, users are guided through the second section, which is about identifying triggers, how to avoid them, and building better habits. The last section is about developing personal strategies that users can use even after the program is over.

The CAARE Program is about getting real. Understanding what causes someone's addiction, why it has such a powerful effect on them, how a user can overcome it, and who they can be when free from it. Customers will not only have access to the videos when they sign up for the course, but will also receive daily emails, have access to the highly-rated book The Secret Addiction©, and more! When a customer signs up for the program they acquire the same training that has helped hundreds of people overcome addiction throughout the years.

This program includes:

  • Lifetime access to ALL Video Lessons and Trainings
  • Downloadable Worksheets
  • Access to Personal Coaches
  • Membership in the Exclusive CAARE Community
  • Ongoing Personal Development
  • 100% Money-Back Guarantee

With the CAARE Program, users can follow a proven plan to break free of addiction, intentionally create the life they want, and live every day forward on their own terms. Best of all, people can seek recovery without spending a fortune or wasting time on shallow and ineffective "one-size-fits-all" addiction programs. Customers can start changing their life today.

To find out more about the CAARE Program or the highly-rated The Secret Addiction© book, please visit

Media Contact:

Dr. Tony DeRamus, D.C.
(936) 890-7234

View original content to download multimedia:

SOURCE Dr. Tony DeRamus, D.C

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.